A detailed history of Simplex Trading, LLC transactions in Seres Therapeutics, Inc. stock. As of the latest transaction made, Simplex Trading, LLC holds 73,871 shares of MCRB stock, worth $53,187. This represents 0.0% of its overall portfolio holdings.

Number of Shares
73,871
Previous 45,311 63.03%
Holding current value
$53,187
Previous $63,000 11.11%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 25, 2024

BUY
$0.75 - $1.56 $21,420 - $44,553
28,560 Added 63.03%
73,871 $56,000
Q4 2023

Feb 02, 2024

SELL
$0.93 - $2.15 $17,567 - $40,613
-18,890 Reduced 29.42%
45,311 $63,000
Q3 2023

Nov 01, 2023

BUY
$2.33 - $5.07 $7,411 - $16,127
3,181 Added 5.21%
64,201 $152,000
Q2 2023

Aug 04, 2023

SELL
$4.67 - $6.55 $252,553 - $354,224
-54,080 Reduced 46.99%
61,020 $292,000
Q1 2023

Apr 27, 2023

BUY
$4.95 - $6.09 $545,277 - $670,856
110,157 Added 2228.55%
115,100 $652,000
Q4 2022

Feb 02, 2023

BUY
$5.09 - $9.05 $25,159 - $44,734
4,943 New
4,943 $27,000
Q1 2022

May 02, 2022

SELL
$6.3 - $8.84 $55,553 - $77,951
-8,818 Closed
0 $0
Q4 2021

Feb 23, 2022

SELL
$6.02 - $11.43 $321,142 - $609,744
-53,346 Reduced 85.81%
8,818 $73,000
Q3 2021

Oct 28, 2021

BUY
$5.46 - $22.6 $70,335 - $291,133
12,882 Added 26.14%
62,164 $1.4 Million
Q2 2021

Aug 12, 2021

BUY
$18.46 - $24.36 $307,192 - $405,374
16,641 Added 50.98%
49,282 $1.18 Million
Q1 2021

Apr 26, 2021

BUY
$17.66 - $28.92 $380,043 - $622,358
21,520 Added 193.51%
32,641 $672,000
Q4 2020

Feb 02, 2021

SELL
$23.25 - $37.73 $597,641 - $969,849
-25,705 Reduced 69.8%
11,121 $272,000
Q3 2020

Oct 14, 2020

BUY
$3.74 - $28.74 $137,729 - $1.06 Million
36,826 New
36,826 $1.04 Million
Q1 2020

Apr 29, 2020

SELL
$2.64 - $3.82 $3,682 - $5,328
-1,395 Closed
0 $0
Q4 2019

Feb 05, 2020

BUY
$2.99 - $4.42 $4,171 - $6,165
1,395 New
1,395 $4,000
Q3 2019

Oct 15, 2019

SELL
$2.29 - $4.16 $20,839 - $37,856
-9,100 Closed
0 $0
Q2 2019

Jul 26, 2019

BUY
$2.28 - $7.35 $20,748 - $66,885
9,100 New
9,100 $29,000
Q1 2018

Apr 26, 2018

SELL
$7.34 - $11.16 $9,527 - $14,485
-1,298 Closed
0 $0
Q4 2017

Jan 10, 2018

SELL
$9.15 - $12.64 $140,727 - $194,403
-15,380 Reduced 92.22%
1,298 $13,000
Q3 2017

Oct 25, 2017

BUY
$12.81 - $16.85 $213,645 - $281,024
16,678
16,678 $267,000

Others Institutions Holding MCRB

About Seres Therapeutics, Inc.


  • Ticker MCRB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 124,072,000
  • Market Cap $89.3M
  • Description
  • Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...
More about MCRB
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.